Literature DB >> 17188357

Non-MHC ligands for inhibitory immune receptors: novel insights and implications for immune regulation.

Robert Jan Lebbink1, Linde Meyaard.   

Abstract

Regulation of cellular responses by inhibitory receptors is crucial for proper function of the immune system. The prototype inhibitory immune receptors are major histocompatibility complex (MHC) class I binding killer-Ig like receptors (KIRs) present on effector cells such as natural killer (NK) cells and effector T cells. However, the recent identification of non-MHC class I ligands for inhibitory immune receptors, such as KLRG1, KLRB1 and LAIR-1, indicates that also MHC class I-independent inhibitory immune receptors play crucial roles in inducing peripheral tolerance. The presence of these receptors on many other immune cell types besides effector cells suggests that tight regulation of cell activation is necessary in all facets of the immune response in both normal and diseased tissue. Here, we review novel insights and implications of non-MHC class I ligand binding to inhibitory immune receptors. We give an overview of the known ligand-receptor pairs by grouping the ligands according to their properties and discuss implications of these interactions for the maintenance of immune balance and for the defense against tumors and pathogens.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17188357     DOI: 10.1016/j.molimm.2006.11.014

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  11 in total

1.  Inhibitory receptor expression on neonatal immune cells.

Authors:  J Walk; G H A Westerlaken; N O van Uden; M E Belderbos; L Meyaard; L J Bont
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

2.  The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity.

Authors:  Noa Stanietsky; Hrvoje Simic; Jurica Arapovic; Amir Toporik; Ofer Levy; Amit Novik; Zurit Levine; Meirav Beiman; Liat Dassa; Hagit Achdout; Noam Stern-Ginossar; Pinhas Tsukerman; Stipan Jonjic; Ofer Mandelboim
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-07       Impact factor: 11.205

Review 3.  Comparative study of tumorigenesis and tumor immunity in invertebrates and nonmammalian vertebrates.

Authors:  Jacques Robert
Journal:  Dev Comp Immunol       Date:  2010-06-02       Impact factor: 3.636

4.  A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature.

Authors:  Sarah Cooley; Feng Xiao; Michelle Pitt; Michelle Gleason; Valarie McCullar; Tracy L Bergemann; Karina L McQueen; Lisbeth A Guethlein; Peter Parham; Jeffrey S Miller
Journal:  Blood       Date:  2007-03-28       Impact factor: 22.113

5.  The interaction between CD300a and phosphatidylserine inhibits tumor cell killing by NK cells.

Authors:  Dikla Lankry; Tihana Lenac Rovis; Stipan Jonjic; Ofer Mandelboim
Journal:  Eur J Immunol       Date:  2013-06-21       Impact factor: 5.532

6.  Differential loss of natural killer cell activity in patients with acute myocardial infarction and stable angina pectoris.

Authors:  Wenwen Yan; Lin Zhou; Siwan Wen; Qianglin Duan; Feifei Huang; Yu Tang; Xiaohong Liu; Yongyan Chai; Lemin Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

7.  Soluble leukocyte-Associated Ig-like Receptor-1 in amniotic fluid is of fetal origin and positively associates with lung compliance.

Authors:  Michiel L Houben; Marloes J M Olde Nordkamp; Peter G J Nikkels; Cornelis K van der Ent; Linde Meyaard; Louis Bont
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

Review 8.  Natural killer cells and immune-checkpoint inhibitor therapy: Current knowledge and new challenges.

Authors:  Alessandro Poggi; Maria Raffaella Zocchi
Journal:  Mol Ther Oncolytics       Date:  2021-11-29       Impact factor: 7.200

9.  Extracellular matrix proteins regulate NK cell function in peripheral tissues.

Authors:  Mark D Bunting; Maulik Vyas; Marta Requesens; Adam Langenbucher; Erik B Schiferle; Robert T Manguso; Michael S Lawrence; Shadmehr Demehri
Journal:  Sci Adv       Date:  2022-03-16       Impact factor: 14.136

10.  Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.

Authors:  Fa-Peng Zhang; Yi-Pei Huang; Wei-Xin Luo; Wan-Yu Deng; Chao-Qun Liu; Lei-Bo Xu; Chao Liu
Journal:  World J Gastroenterol       Date:  2020-01-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.